Choroidal detachment

H7_CHORDETACH

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H31.4
  • Hospital discharge: ICD-9 3637
  • Hospital discharge: ICD-8 3785
  • Cause of death: ICD-10 H31.4
  • Cause of death: ICD-9 3637
  • Cause of death: ICD-8 3785

2 out of 7 registries used, show all original rules.

90

4. Check minimum number of events

None

90

5. Include endpoints

None

90

6. Filter based on genotype QC (FinnGen only)

87

Control definitions (FinnGen only)

Control exclude
H7_CHOROIDRETINA

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H31
Name in latin
Ablatio chorioideae

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 799 431 358
Only index persons 630 346 284
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 73.78 76.13 70.93
Only index persons 73.34 76.49 69.51

-FinnGen-

Key figures

All Female Male
Number of individuals 87 40 47
Unadjusted period prevalence (%) 0.02 0.01 0.02
Median age at first event (years) 71.87 71.23 72.42

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
90
Matched controls
900
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H31.4
ICD-10 Finland
Choroidal detachment
+∞
119.2
86
*
S01ED51
ATC
timolol, combinations; ophthalmic
34.5
67.6
59
47
114
Kela drug reimbursment
Glaucoma
21.2
50.3
55
62
Z96.1
ICD-10 Finland
Presence of intraocular lens
15.3
39.1
61
109
S01ED01
ATC
timolol; ophthalmic
19.3
35.1
32
25
S01EE01
ATC
latanoprost; ophthalmic
15.4
34.0
37
39
S01EC01
ATC
acetazolamide; systemic
53.3
30.8
36
11
S01EA05
ATC
brimonidine; ophthalmic
47.1
30.8
37
13
XCK00
NOMESCO Finland
Perimetry
13.8
26.5
29
30
CHD65
NOMESCO Finland
Nonpenetrating glaucoma surgery
107.4
23.0
24
*
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
29.2
22.3
30
15
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
19.9
20.2
31
23
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
11.3
20.1
77
310
S01EX03, ,
ATC
32.5
20.1
26
11
S01EC04
ATC
brinzolamide; ophthalmic
23.3
19.5
28
17
H33.0
ICD-10 Finland
Retinal detachment with retinal break
+∞
19.5
18
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
10.4
19.3
25
32
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
7.6
18.2
68
259
S01EC03
ATC
dorzolamide; ophthalmic
33.7
18.0
23
9
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
9.2
17.5
25
36
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
+∞
15.0
14
*
WX140
NOMESCO Finland
Parabulbar anesthesy
22.3
14.7
21
12
XCK10
NOMESCO Finland
Photography of fundus of eye
7.3
14.3
25
45
S01EE03
ATC
bimatoprost; ophthalmic
47.9
13.7
16
*
CHD00
NOMESCO Finland
Laser trabeculoplasty
35.5
12.1
15
5
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
+∞
11.7
11
*
CHC05
NOMESCO Finland
Iridotomy
29.6
11.6
15
6
S01EE05
ATC
tafluprost; ophthalmic
13.2
11.5
20
19
S01EE04
ATC
travoprost; ophthalmic
25.3
11.1
15
7
S01EA03
ATC
apraclonidine; ophthalmic
32.7
11.1
14
5
S01EC54
ATC
brinzolamide, combinations; ophthalmic
32.7
11.1
14
5
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.2
11.0
29
76
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
68.4
10.9
12
*
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
123.8
10.7
11
*
CHD99
NOMESCO Finland
Other filtering operation
61.9
9.9
11
*
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
14.7
9.8
16
13
CHD35
NOMESCO Finland
Laser goniopuncture
111.2
9.6
10
*
CHD15
NOMESCO Finland
Trabeculectomy and iridectomy
41.2
9.2
11
*
CJB10
NOMESCO Finland
Laser discission of secondary cataract
5.2
9.1
22
53
H25.1
ICD-10 Finland
Senile nuclear cataract
3.9
9.0
56
269
XCH00
NOMESCO Finland
Eye pressure measurement
10.2
8.8
17
20
H26.4
ICD-10 Finland
After-cataract
4.8
8.3
22
57
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
14.9
8.2
13
10
S01BA07
ATC
fluorometholone; ophthalmic
49.4
7.9
9
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
3.5
7.6
57
298
H57.1
ICD-10 Finland
Ocular pain
12.4
7.6
13
12
H20.1
ICD-10 Finland
Chronic iridocyclitis
+∞
7.4
7
*
CHD10
NOMESCO Finland
Trabeculectomy
+∞
7.4
7
*
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
+∞
7.4
7
*
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
43.5
6.9
8
*
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
43.5
6.9
8
*
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
24.7
6.8
9
*
H16.0
ICD-10 Finland
Corneal ulcer
11.3
6.8
12
12
S01EB01
ATC
pilocarpine; ophthalmic
28.9
6.3
8
*
3708
FHL
Trabeculectomy or equivalent
+∞
6.3
6
*
S01BC05
ATC
ketorolac; ophthalmic
6.2
6.2
16
30
S01ED02
ATC
betaxolol; ophthalmic
16.4
6.0
9
6
S01BC03
ATC
diclofenac; ophthalmic
16.4
6.0
9
6

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
46
283
2.28
3.60
4.8
4.3
0.00
0.00
estimate
-0.00
11
54
46
286
2.24
3.48
6.3
5.7
0.00
0.00
estimate
—
10
50
46
290
2.20
3.32
4.9
4.3
0.00
0.00
estimate
—
9
48
56
396
2.10
2.86
4.5
4.8
—
—
—
0
0
48
323
2.04
2.78
5.8
6.9
1.20
1.22
mmol/l
0.89
41
276
26
142
2.17
2.59
2.7
3.6
551.81
540.69
mosm/kgh2o
0.06
16
123
27
157
2.03
2.26
5.2
4.1
—
—
—
0
0
37
241
1.91
2.24
4.1
4.0
106.69
122.43
e6/l
0.08
27
169
18
90
2.25
2.19
2.6
6.4
11.07
11.29
kpa
0.10
18
85
18
90
2.25
2.19
2.6
6.4
4.87
5.02
kpa
0.23
18
85
10
38
2.83
2.08
3.0
3.0
0.11
0.08
e6/l
—
10
38
14
64
2.41
2.07
1.6
1.6
—
—
—
0
0
33
212
1.88
2.06
3.3
3.4
22.68
375.11
e6/l
0.59
25
159
27
163
1.94
2.02
2.4
2.1
3.14
3.22
mg/l
0.03
22
141
5
11
4.74
1.97
1.2
1.4
—
—
—
0
0
52
389
1.80
1.95
5.8
5.3
—
4229.79
—
0
14
7
23
3.21
1.84
4.0
3.0
—
—
—
0
0
30
194
1.82
1.80
4.8
4.6
—
—
—
0
0
17
90
2.10
1.80
2.7
6.5
0.82
0.96
mmol/l
—
9
69
20
113
1.99
1.79
2.8
2.9
0.73
2.59
e6/l
—
10
59
10
43
2.49
1.65
1.4
4.3
—
—
—
0
0
33
225
1.74
1.64
3.2
4.1
—
5.73
—
0
13
32
220
1.71
1.53
4.2
3.5
—
—
—
0
0
53
419
1.64
1.47
4.0
4.0
15.10
15.25
pmol/l
0.17
46
369
30
207
1.67
1.41
1.9
2.2
—
—
—
0
0
9
43
2.21
1.35
8.3
2.6
—
—
—
0
0
38
283
1.59
1.31
7.1
5.5
0.17
0.19
e9/l
0.37
33
253
23
151
1.70
1.28
6.6
4.9
0.00
0.00
estimate
—
9
47
37
277
1.57
1.23
7.2
5.3
0.59
0.62
e9/l
0.30
31
246
37
277
1.57
1.23
7.2
5.3
0.04
0.04
e9/l
0.01
31
246
34
250
1.58
1.22
7.8
6.3
—
—
—
0
0
28
197
1.61
1.20
3.0
3.3
0.08
0.39
e6/l
1.98
20
142
16
96
1.81
1.20
4.5
6.6
104.50
103.63
mmol/l
0.30
16
96
7
30
2.44
1.15
1.6
5.1
—
—
—
0
0
10
52
2.04
1.11
2.8
3.6
—
—
—
0
0
9
46
2.06
1.07
5.0
2.8
1.14
1.22
%
—
9
46
9
46
2.06
1.07
1.2
3.2
—
—
—
0
0
17
110
1.67
0.99
1.2
1.1
0.77
3.41
u/ml
—
7
30
22
153
1.58
0.98
2.1
1.8
506.07
458.35
pmol/l
0.21
14
125
25
180
1.54
0.96
3.8
3.4
—
—
—
0
0
8
43
1.94
0.90
1.6
1.3
—
—
—
0
0
8
43
1.94
0.90
3.1
7.6
91.24
94.09
%
—
8
43
28
210
1.48
0.89
3.5
4.7
7.36
7.40
ph
—
5
29
6
30
2.07
0.89
9.0
4.4
—
—
—
0
0
8
44
1.90
0.88
5.4
2.8
0.54
0.75
%
—
8
44
21
148
1.55
0.88
1.7
1.8
1092.92
1147.79
nmol/l
0.07
12
111
49
412
1.42
0.84
4.4
4.5
—
—
—
0
0
19
134
1.53
0.80
4.3
3.9
—
—
—
0
0
35
280
1.41
0.79
2.1
2.2
98.49
92.67
pmol/l
0.25
15
139
60
527
1.42
0.78
5.0
4.9
1.71
2.03
mu/l
1.74
54
456
5
23
2.24
0.77
5.4
2.9
28.00
78.89
u/ml
—
5
23
40
329
1.39
0.76
15.3
19.7
1.10
1.38
inr
3.44
14
96
24
180
1.45
0.76
3.9
2.4
54.54
80.98
u/l
0.53
24
169
26
199
1.43
0.74
4.8
4.4
—
—
—
0
0
32
256
1.39
0.71
16.3
9.9
0.00
0.00
e9/l
0.49
26
215
19
138
1.48
0.70
2.4
3.1
2.48
2.47
mmol/l
0.12
13
122
61
543
1.38
0.69
4.5
4.7
4.40
4.35
mmol/l
0.12
54
489
29
230
1.38
0.67
5.6
4.6
1.52
2.58
ug/l
0.98
24
198
5
28
1.83
0.67
1.6
1.0
—
—
—
0
0
60
535
1.36
0.65
7.1
6.5
42.44
41.50
mmol/mol
0.24
55
490
16
114
1.49
0.64
8.6
5.0
1.02
1.02
kg/l
—
5
17
24
186
1.40
0.63
2.3
2.1
—
—
—
0
0
34
284
1.32
0.56
5.7
5.0
44.08
47.02
ng/l
0.07
23
219
14
100
1.47
0.56
1.4
1.3
2.06
2.57
g/l
—
8
54
6
38
1.62
0.55
3.0
4.3
25.12
25.04
mmol/l
—
6
38
14
102
1.44
0.51
2.9
2.5
10.51
10.68
umol/l
0.03
14
93
7
46
1.56
0.49
1.9
1.3
—
—
—
0
0
59
537
1.29
0.48
4.2
4.7
1.39
1.43
mmol/l
0.25
53
478
0
15
0.00
0.41
0.0
2.7
—
—
—
0
0
61
563
1.26
0.41
5.5
5.4
2.62
2.51
mmol/l
0.37
55
505
5
34
1.50
0.41
1.6
2.7
—
—
—
0
0
64
595
1.26
0.40
19.8
15.7
—
—
—
0
0
5
35
1.45
0.40
1.2
1.3
—
—
—
0
0
14
178
0.75
0.39
1.9
1.8
19.34
20.97
nmol/l
0.26
14
153
56
514
1.24
0.39
3.9
4.3
1.25
1.24
mmol/l
0.06
49
456
6
41
1.50
0.37
1.8
1.3
—
—
—
0
0
6
43
1.42
0.36
2.0
1.5
—
—
—
0
0
64
599
1.24
0.35
27.8
21.0
94.53
84.67
umol/l
0.58
64
599
8
108
0.72
0.31
1.0
1.8
30.38
30.02
s
—
8
103
62
582
1.21
0.31
22.9
17.0
26.41
26.05
mg/l
0.03
50
464
7
56
1.27
0.30
6.6
3.4
—
—
—
0
0
10
76
1.36
0.29
1.2
1.2
—
—
—
0
0
8
63
1.30
0.29
6.8
7.7
—
—
—
0
0
66
629
1.18
0.24
31.5
25.0
130.44
131.96
g/l
0.28
66
605
66
629
1.18
0.24
31.1
24.8
38.56
39.25
%
0.25
58
575
23
202
1.19
0.23
3.1
3.6
21.72
6.09
mg/mmol
0.38
12
129
12
98
1.26
0.22
3.2
2.4
2.29
2.14
g/l
0.41
12
89
0
11
0.00
0.21
0.0
2.5
—
59.63
—
0
11
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
5.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
6
49
1.24
0.20
6.3
4.3
—
—
—
0
0
6
49
1.24
0.20
2.2
1.6
—
—
—
0
0
7
60
1.18
0.18
1.6
1.2
—
—
—
0
0
19
169
1.16
0.16
2.1
3.3
—
—
—
0
0
9
80
1.14
0.16
4.9
4.0
—
—
—
0
0
10
87
1.17
0.10
7.9
5.1
1.26
1.04
mmol/l
—
10
77
18
165
1.11
0.09
10.6
7.0
—
—
—
0
0
14
127
1.12
0.08
2.8
3.0
0.54
0.88
ug/l
—
7
89
20
186
1.10
0.08
2.8
2.9
117.07
33.65
mg/l
0.41
14
127
9
83
1.09
0.07
1.6
1.6
—
—
—
0
0
14
128
1.11
0.07
1.6
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.3
—
57.00
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
40.82
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
28.28
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
11.35
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
0.33
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
23.50
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
262.33
—
0
6

Mortality – FinRegistry

Association

Association between endpoint H7_CHORDETACH and mortality.

Females

Parameter HR [95% CI] p-value
H7_CHORDETACH 0.994 [0.82, 1.21] 0.953
Birth year 0.994 [0.99, 1.0] 0.199

During the follow-up period (1.1.1998 — 31.12.2019), 151 out of 331 females with H7_CHORDETACH died.

Males

Parameter HR [95% CI] p-value
H7_CHORDETACH 0.9 [0.7, 1.15] 0.399
Birth year 0.987 [0.98, 1.0] 0.01

During the follow-up period (1.1.1998 — 31.12.2019), 108 out of 260 males with H7_CHORDETACH died.

Mortality risk

Mortality risk for people of age

years, who have H7_CHORDETACH.

N-year risk Females Males
1 0.071% 0.169%
5 0.545% 0.93%
10 1.404% 2.5%
15 2.849% 5.043%
20 4.983% 8.75%

Relationships between endpoints

Index endpoint: H7_CHORDETACH – Choroidal detachment

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data